BioSpace News Archive

Biotech Bay

Kodiak Sciences Announces Upcoming Presentation of Durability Data from Clinical Development Program of KSI-301 in Wet AMD, DME, and RVO at American Academy of Ophthalmology 2019 Annual Meeting

Kodiak Sciences Inc. announced that Charles C. Wykoff, M.D., Ph.D., will present first-time results at the Annual Meeting of the American Academy of Ophthalmology (AAO) to be held in San Francisco, California.

October 7, 2019
·
5 min read
Genetown

Korro Bio Launched to Advance Groundbreaking New Approach to Nucleic Acid Editing

Atlas Venture announced the launch of Korro Bio, Inc., a new company created to lead the rapidly advancing field of RNA editing.

October 7, 2019
·
2 min read
Biotech Beach

UCLA Neurosurgery Golden Visionary Ball 2019 Honors

Lauren B. Leichtman and Arthur E. Levine, Elizabeth Gabler, Frank Gehry, and Dr. Ronald W. Busuttil in University’s Centennial Year Renée Bargh will Emcee; Performance by Angel City Chorale

October 7, 2019
·
2 min read
Genetown

Sojournix CEO Speaks Today at LSX World Congress USA

Sojournix announces that Daniel Grau, President and Chief Executive Officer of Sojournix, will present at the LSX World Congress USA at the Convene Convention Center in Boston.

October 7, 2019
·
1 min read
TerrAscend Canada Triples Licensed Cultivation and Processing Capacity

TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) (“TerrAscend” or “the Company”), the first and only global cannabis company licensed for sales in Canada, the US, and the EU, today announced that it has received approval from Health Canada for significant expansion at its facility in Mississauga, Ontario.

October 7, 2019
·
6 min read
Job Trends

Newly Published Systematic Review Confirms Strength of Evidence and Outlines Appropriate Use Criteria for Integration of DecisionDx-Melanoma in Management of Patients with Cutaneous Melanoma

Study published recently in SKIN: The Journal of Cutaneous Medicine

October 7, 2019
·
3 min read
Drug Development

Nektar Therapeutics Announces Initiation of Two Clinical Studies of Novel T Regulatory Cell Stimulator NKTR-358 (LY3471851) in Patients with Psoriasis and Atopic Dermatitis

Nektar Therapeutics (NASDAQ: NKTR) today announced the initiation of two Phase 1b studies of NKTR-358 (LY3471851*), a novel T regulatory (Treg) cell stimulator, one in patients with psoriasis and one in patients with atopic dermatitis.

October 7, 2019
·
8 min read
Genetown

Decibel Therapeutics to Provide Corporate Update at Jefferies Gene Therapy Summit

Decibel Therapeutics, a clinical-stage biotechnology company developing novel therapeutics for hearing loss and balance disorders, will provide a corporate update at the upcoming Jefferies Gene Therapy Summit in New York City on Tuesday, October 8, 2019 at 9:45 a.m. ET.

October 7, 2019
·
2 min read
Drug Development

BiondVax Receives €4M From the European Investment Bank (EIB) in Support of Ongoing Universal Influenza Vaccine Pivotal Phase 3 Trial

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV), a phase 3 clinical stage biopharmaceutical company focused on developing and commercializing the M-001 clinical Phase 3 Universal Influenza Vaccine candidate, announced today the receipt of €4 million from the European Investment Bank (EIB).

October 7, 2019
·
4 min read
Business

Cannabics Pharmaceuticals Appoints Company’s Founder to Its Board of Directors

Itamar Borochov Joins the Board of Directors Effective Immediately

October 7, 2019
·
3 min read